Back to medications
Medication monograph

roflumilast

Phosphodiesterase-4 (PDE4) InhibitorsAnti-inflammatory AgentsPhosphodiesterase 4 Inhibitors

Clinical reference

Product monograph

ZORYVE- roflumilast cream

ROFLUMILAST tablet

ZORYVE- roflumilast aerosol, foam

Brands & formulations

Family members

DAXAS

Marketed
500 MCGORALTABLET[ "roflumilast" ]
Product monograph

ZORYVE

Marketed
0.3 %TOPICALCREAM[ "roflumilast" ]
Product monograph

ZORYVE

Marketed
0.3 %TOPICALFOAM[ "roflumilast" ]
Product monograph

ZORYVE

Marketed
0.15 %TOPICALCREAM[ "roflumilast" ]
Product monograph

Pricing

Price information

Daliresp

AstraZeneca · 500 mcg

30: $159.9990: $499.99

Zoryve Cream

Arcutis Canada Inc. · 0.15 %/60 gm

1: $557.13

Classification

Chemical class
Phosphodiesterase-4 (PDE4) Inhibitors
Clinical class
Anti-inflammatory Agents
Banks class
Phosphodiesterase 4 Inhibitors